Details for Patent: 4,536,386
✉ Email this page to a colleague
Summary for Patent: 4,536,386
Title: | Method of controlling emesis caused by cisplatin in cancer chemotherapy |
Abstract: | High dosages of metoclopramide or a pharmaceutical salt thereof is administered intravenously to human cancer patients undergoing cisplatin chemotherapy to prevent emesis. |
Inventor(s): | Keenan; Robert E. (Richmond, VA) |
Assignee: | A. H. Robins Company, Inc. (Richmond, VA) |
Application Number: | 06/508,367 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 4,536,386
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |